Partner Headlines - BCRX

  1. UPDATE: BioCryst Pharmaceuticals Posts Narrower-Than-Expected ...

    Benzinga
  2. Benzinga's Top #PreMarket Gainers

    Benzinga
  3. Biotechs Presenting At The J.P. Morgan Healthcare Conference: ...

    Benzinga
  4. Viral Investing: Ebola Drug Makers' Varied Strategies

    IBD
  5. US Stock Futures Edge Higher Ahead Of Economic Data

    Benzinga
  6. BioCryst Pharmaceuticals'

    IBD
  7. Monday's #PreMarket Movers: Caesars, Enta, Twitter And More

    Benzinga
  8. Benzinga's Top #PreMarket Gainers

    Benzinga
  9. US Stock Futures Signal Higher Start On Wall Street

    Benzinga
  10. Market Mixed Amid Plan To Spend $300 Million On Ebola Vaccines

    Benzinga
  11. UPDATE: Bank Of America Reiterates On BioCryst Pharmaceuticals ...

    Benzinga
  12. Ebola Vaccine Contenders

    Benzinga
  13. Making Money With Charles Payne: 10/24/14

    FoxBusiness
  14. Stomach-Churning Ride for Ebola Stocks

    FoxBusiness
  15. Sarepta Therapeutics Shares Up On Ebola Drug Safety Study

    Benzinga
  16. Making Money With Charles Payne: 10/16/14

    FoxBusiness
  17. Making Money With Charles Payne: 10/08/14

    FoxBusiness
  18. Ebola Patient Eric Duncan Dies; Related Stocks Fall On News

    Benzinga
  19. US Stock Futures Edge Higher Ahead Of Alcoa Earnings, Fed Minutes

    Benzinga
  20. Making Money With Charles Payne: 10/07/14

    FoxBusiness
  21. Benzinga's Top #PreMarket Gainers

    Benzinga
  22. BioCryst Reports Late Breaker Presentation of OPuS-1 Phase 2 ...

    Benzinga
  23. Making Money With Charles Payne: 10/0614

    FoxBusiness
  24. Chimerix Ebola Drug OK'd; Tekmira Drops On Downgrade

    IBD
  25. Ebola Sector Shake Out Leaves Chimerix Inc On Top

    Benzinga
  26. U.S. Stocks Turn Red; CareFusion Shares Surge On Announcement ...

    Benzinga
  27. Markets Open Higher; Hewlett-Packard Plans To Split Into Two ...

    Benzinga
  28. Jobs Data Boost Stock Futures; Salix, Tekmira, Iamgold Rising

    IBD
  29. Making Money With Charles Payne: 10/01/14

    FoxBusiness
  30. Ebola-Related Pharma Stocks Soar On First U.S. Case

    IBD
  31. Morning Market Movers

    Benzinga
  32. Making Money With Charles Payne: 09/30/14

    FoxBusiness
  33. Dow Jumps 170 Points; Bed Bath & Beyond Shares Rise On Upbeat ...

    Benzinga
  34. U.S. Stocks Rise; Accenture Shares Decline On Weak Forecast

    Benzinga
  35. BioCryst Receives Additional NIAID Funding For Manufacture and ...

    Benzinga
  36. Momentum Stocks Showing Weakness

    Benzinga
  37. BioCryst Announces RAPIVAB Trial Results For The Treatment Of ...

    Benzinga
  38. BioCryst Pharmaceuticals, Inc. Sinks; WHO Notes Ebola Safety ...

    Benzinga
  39. BioCryst To Present Peramivir Trial Results For The Treatment ...

    Benzinga
  40. US Stock Futures Gain Ahead Of Consumer Data

    Benzinga
  41. Biotechs That Might Benefit From Ebola

    Benzinga
  42. Benzinga's Top #PreMarket Gainers

    Benzinga
  43. Stocks Hitting 52-Week Highs

    Benzinga
  44. Benzinga's Top Initiations

    Benzinga
  45. JP Morgan Initiates BioCryst Pharmaceuticals At Overweight

    Benzinga
  46. MLV & Co Sees Positive Momentum Going Into 2H14 For BioCryst ...

    Benzinga
  47. Ebola Stocks Continue Higher

    Benzinga
  48. UPDATE: Wells Fargo Upgrades BioCryst

    Benzinga
  49. UPDATE: H.C. Wainwright & Co. Initiates Coverage on BioCryst ...

    Benzinga
  50. Benzinga's Top Initiations

    Benzinga
  51. Morning Movers for Feb. 25, 2014: IMUC, MSO, ZU, CARA, VSI, TSLA, ...

    Benzinga
  52. Benzinga's Top #PreMarket Gainers

    Benzinga
  53. Benzinga's Top Downgrades

    Benzinga
  54. Benzinga's Top Initiations

    Benzinga
  55. UPDATE: JMP Securities Places BioCryst Pharmaceuticals PT Under ...

    Benzinga
  56. US Stock Futures Gain Ahead Of GDP Data

    Benzinga
  57. BioCryst Files Peramivir NDA for Influenza

    Benzinga
  58. Benzinga's Top #PreMarket Gainers

    Benzinga
  59. BioCryst Selects Two Plasma Kallikrein Inhibitors for Hereditary ...

    Benzinga
  60. BioCryst Initiates Phase 2a Clinical Trial of BCX4161 in Patients ...

    Benzinga
  61. Benzinga's Top Pre-Market Gainers

    Benzinga
  62. BioCryst Awarded Up to $22M Contract by the NIAID to Develop ...

    Benzinga
  63. JMP Calls BioCryst's Oral Kallikrein 'Potential Game Changer,' ...

    Benzinga
  64. UPDATE: JMP Securities Raises PT on BioCryst Pharmaceuticals ...

    Benzinga
  65. Benzinga's Top Pre-Market Gainers

    Benzinga
  66. FDA Removes Clinical Hold on BioCryst's BCX 4161 -8K

    Benzinga
  67. Benzinga's Top Pre-Market Gainers

    Benzinga
  68. BioCryst Prices 4M Share Offering at $4.40/Share

    Benzinga
  69. UPDATE: Bank of America Downgrades BioCryst Pharmaceuticals on ...

    Benzinga
  70. Benzinga's Top Pre-Market Losers

    Benzinga
  71. UPDATE: Bank of America Resumes Coverage on BioCryst Pharmaceuticals ...

    Benzinga
  72. Benzinga's Small Cap Movers for Wednesday January 2, 2013

    Benzinga
  73. Ballots Are In: Worst CEO in the Biotech Industry Is . . .

    YCharts
  74. BioCryst Pharmaceuticals, Presidio Pharmaceuticals Terminate ...

    Benzinga
  75. BioCryst Broad-Spectrum Antiviral BCX4430 Shows Effective and ...

    Benzinga
  76. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  77. BioCryst Announces Withdrawal of BCX5191 Investigational New ...

    Benzinga
  78. Benzinga's M&A Chatter for Thursday October 18, 2012

    Benzinga
  79. BioCryst Pharmaceuticals and Presidio Pharmaceuticals to Merge

    Benzinga
  80. BioCryst Pharmaceuticals, Presidio Pharmaceuticals to Merge

    Benzinga
  81. BioCryst Pharmaceuticals Inc. Reports Operating Results (10-Q)

    GuruFocus
  82. A Peek Into The Market Before The Trading Starts

    Benzinga
  83. IHS, Ebix Included in Stocks Up on High Volume Friday

    FoxBusiness
  84. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  85. Swine Flu Has BioPharma as Happy as Pigs in Filth

    Benzinga
  86. Swine Flu Outbreak in Mexico Sends Small BioPharma Sky-High

    Benzinga
  87. Benzinga's Microcap Movers for Thursday January 12, 2012

    Benzinga
  88. Oink Oink: Profit From The Return Of Swine Flu

    Benzinga
  89. UPDATE: Bank of America Meets with BioCryst Pharma Management ...

    Benzinga
  90. Bank of America Comments on BCRX Phase-3 Data

    Benzinga
  91. BoardCentral StockTalk - weekly update: AAPL, F, MSFT, KERX, ...

    BoardCentral
Trading Center